After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first American death caused by the H5N1 bird flu.

Novavax has a bird flu vaccine in clinical trials in addition to a COVID-19/influenza combination vaccine in late-stage trials. 33-year-old American living in Germany: ‘I don’t worry about not ...

Investing.com - European stock markets closed lower on Friday, despite US jobs report showing that US economy unexpectedly added more jobs in December compared to the prior month. The US jobs ...

The approval of Novavax' COVID-19 vaccine in Great Britain could help the country save a "considerable amount of money" if it is used in future booster campaigns, according to the former chair of ...

Werbel reported receiving consulting fees from and serving on the advisory boards of AstraZeneca and Novavax; consulting fees from the CDC and the Infectious Diseases Society of America ...

There’s a number of remote job websites and strategies you can use to increase the likelihood you find a full-time remote job in a field you love. Full-time jobs that allow you to work from home can ...

The Centers for Disease Control (CDC) yesterday announced that it would make 200,000 doses of a protein-based Novavax vaccine targeting the JN.1 subvariant of COVID-19 available to the public from ...

“One of the clearest indications of a cooling labor market has been the ongoing pullback in job postings from their March 2022 peak. As of November 2024, the Indeed Job Posting Index was down 10 ...

Consumer spending figures also remain robust, indicating a resilient economy, according to Indeed’s 2025 U.S. Jobs and Hiring Trends Report. However, there is still lingering uncertainty ...

As you can see from the chart above the percentage of shares that are sold short for Novavax has declined since its last report. This does not mean that the stock is going to rise in the near-term ...